BioSpace News Archive

Immunexpress, Pty Ltd & Inc. announced that it has been successfully certified according to ISO 13485:2016 & EN ISO 13485:2016, the international standard for medical device quality management systems.

Hospital for Special Surgery announced the appointment of S. Louis Bridges, Jr., MD, PhD, as the new Physician-in-Chief and Chair of the Division of Rheumatology, effective September 1, 2020.

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, March 5, 2020 to report its fourth quarter and full year 2019 financial results and provide a corporate update.

Continued Relationships with Health Insurers Reflect the Need for High-quality, High-value Care as Cancer Treatments Become Increasingly Complex

RareCyte announces a liquid biopsy blood test for programmed death-ligand 1, enabling customers to evaluate PD-L1 expression on circulating tumor cells with industry leading sensitivity.

Developments for CELLSEARCH and DEPArray Technologies to be Featured at the Molecular Medicine Tri-Conference [27-February-2020] BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. , Feb. 27, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help adva

NEW UST Video Release - Solving Complex Formulation & Processing Challenges

zPREDICTA is the leading provider of tumor-specific 3D cell culture models for the in vitro testing of anti-cancer therapeutics.

BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced its Chief Science Officer, Dr. Ravi Birla, has published a paper in the prestigious APL Bioengineering scholarly journal.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), today announced that it has commenced the production of its proprietary Cannabigerol (“CBG”) isolate infused version of Tauri-Gum.